Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice

Clinical trial NCT02655159 · TERMINATED

Trial details

NCT number: NCT02655159
Sponsor: Celgene Corporation
Status: TERMINATED
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2016-01-01
Primary completion: 2016-08-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.